A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy - Concepedia

Concepedia

Publication | Closed Access

A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy

71

Citations

36

References

2003

Year

Francis J. Giles, Roberto Rodríguez, Daniel J. Weisdorf, John R. Wingard, Paul J. Martin, Thomas R. Fleming, Stuart L. Goldberg, Elias Anaissie, Brian J. Bolwell, Nelson J. Chao,

Leukemia Research

MedicinePhase IiiPathologyStomatotoxic ChemotherapyOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1